At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories. That it depends thereby less on large names, but on the future potential and whether the market also recognizes these perspectives, was one of its first learnings at the stock exchange.
On these pages, Nico examines current events at listed companies and takes a closer look at companies that are traded under the radar of the market, in addition to well-known securities.
In order to be able to take advantage of speculative opportunities on the stock exchange, Nico not only focuses on a balanced asset allocation of defensive and opportunity-oriented securities, but also on an intact risk management. "In addition to position size and entry in several tranches, investors should also develop a sense of timing and get to know a stock better before investing," says the columnist.
Commented by Nico Popp
Commented by Nico Popp on December 19th, 2022 | 13:55 CET
Gold price at USD 3,600? flatexDegiro, Globex Mining, Uniper
Year-end rally? No chance! The central banks have put a spanner in the works of optimists one week before the festive season. The continued tough stance against inflation is again fueling fears of a recession. There are cracks in the woodwork, and some observers even believe that gold could stand at USD 3,600. We shed light on the situation and discuss three stocks.
Read
Commented by Nico Popp on December 15th, 2022 | 10:48 CET
Gold Rally! Why precious metals offer themselves now: Barrick Gold, Tocvan Ventures, Steinhoff
Especially during uncertain stock market times, it pays to keep an eye on various asset classes. One of them, namely gold, has recently delivered the first rally signals. In this article, we outline what this means for investors and why precious metals are not a question of faith. What are the alternatives to gold, and what stocks offer opportunities now?
Read
Commented by Nico Popp on December 14th, 2022 | 11:58 CET
Hydrogen: Where things get tight, where opportunities lurk - NEL, First Hydrogen, Amazon
Hydrogen is picking up speed! In northern Germany, the first hydrogen trains recently went into regular service. At the same time, decision-makers from Spain, France and Portugal are working with the EU on a hydrogen pipeline from Barcelona to Marseille. From 2030, green hydrogen should also flow indirectly through this pipeline to Germany. We present companies that could benefit and are already setting the course for tomorrow.
Read
Commented by Nico Popp on December 12th, 2022 | 11:21 CET
Oil price shock! Money is made here: Shell, Saturn Oil + Gas, Siemens Energy
OPEC+, i.e. the oil cartel plus other oil-producing countries such as Russia, Oman, Kazakhstan and Mexico, cut oil production a few days ago. Viennese economist Franz Wirl believes the measure is too drastic. He and other observers suspect that OPEC+ wants to cash in again, given an impending recession. What role does the OPEC+ decision have for the oil price, and which stocks can profit? We provide answers!
Read
Commented by Nico Popp on December 9th, 2022 | 14:50 CET
Interview Smartbroker: On new paths to old goals
With the Smartbroker 2.0 project, the Berlin-based company wanted to set the course for a golden future. The plan to develop large parts of the brokerage backend itself has been shelved, and the Company has introduced a new partner - Baader Bank. In this interview, find out what the new direction will mean for customers and shareholders and why Smartbroker CEO André Kolbinger announces "hard work and less talk" for 2023.
Read
Commented by Nico Popp on December 8th, 2022 | 09:05 CET
Where the money is made: BioNTech, Novavax, Cardiol Therapeutics
While the first federal states in Germany are lifting the mask requirement on public transport, suppliers of vaccines and medicines are far from going back to normal. Even corona vaccines are in high demand. While there is a shortage of antipyretics and medication in this country, especially for children, innovative companies are already addressing the next challenges. We explain where investors can make money.
Read
Commented by Nico Popp on December 7th, 2022 | 09:45 CET
Volkswagen, Altech Advanced Materials, NIO: Where does the starting signal come from?
The whole world is currently investing in renewable energy and storage solutions. Germany, in particular, is considered a pioneer when it comes to promoting environmentally friendly energy sources. However, it looks as if other regions, such as Asia and North America, are overtaking Europe. We look at what the current situation means for investors and which companies can profit regardless of the situation in Germany.
Read
Commented by Nico Popp on December 5th, 2022 | 10:36 CET
Where gold shines brightest: Barrick Gold, Desert Gold, Uniper
Secretly and quietly, gold has stalked towards the USD 1,800 mark. The reasons are the weaker dollar in combination with a possible end of the interest rate turnaround and the growing uncertainty: Even if current economic data, such as the recently published US labor market report, give hope, the risks are growing in the long term. We look at two exciting gold stocks and use the example of Uniper to explain why gold could soon be booming.
Read
Commented by Nico Popp on December 5th, 2022 | 10:14 CET
Investment stories that inspire: Freyr Battery, Manuka Resources, BASF
In order to be successful with stocks in the current market situation, a thorough analysis of companies and their business models is required. Blanket instructions for action do not lead to success. Investment strategies such as the value approach and the focus on unconditional growth are not guaranteed to lead to success. What matters now are convincing investment stories! We take a look at three stocks that are currently in focus and check their future.
Read
Commented by Nico Popp on November 30th, 2022 | 13:33 CET
Advances in the fight against cancer: Arcus Biosciences, Gilead Sciences, Defence Therapeutics, BioNTech
Research studies from 2020 show that 72% of Germans fear cancer. However, very few people want to admit to these fears. But precisely because the subject is a big taboo, it is worth looking at the latest achievements in research. Many companies worldwide have long been fighting the epidemic - and making astonishing progress. Just recently, a US biotech announced encouraging study results. Other companies have yet to launch promising studies. We provide an overview and outline opportunities from an investor's perspective.
Read